Oncology
Trever Bivona, M.D., PH.D.
Professor of Medicine and of Cellular and Molecular Pharmacology
Trever G. Bivona, MD, PhD, is a board-certified medical oncologist and laboratory-based physician-scientist at the University of California, San Francisco (UCSF), specializing in thoracic oncology with a focus on lung cancer. He treats patients with advanced lung malignancies harboring oncogenic mutations, including EGFR, ALK, KRAS, and RAS pathway alterations. His clinical practice integrates precision medicine approaches, leveraging molecular profiling to guide targeted therapies such as EGFR
21+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (ABIM)
Education & Training
- New York University School of Medicine — MD, PhD
- New York University School of Medicine Ph.D. 2004 Cell and Molecular Biology
- New York University School of Medicine M.D. 2005
- Memorial Sloan-Kettering Cancer Center — Fellowship, Medical Oncology and Post-doctoral Research
- Memorial Sloan Kettering Cancer Center 2011 Medical Oncology and cancer biology post-doctoral fellowship
Peer Recognition
- NIH — Director's New Innovator Award
2011
- NIH — Director’s New Innovator Award
2011
2015
Recognition & Leadership
Awards & Honors
- NIH Director's New Innovator Award
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- UCSF Helen Diller Family Comprehensive Cancer Center
- UCSF Medical Center
Languages
English
Experience
21+ years in practice